<DOC>
	<DOCNO>NCT00425438</DOCNO>
	<brief_summary>This 2 arm study compare efficacy safety CellCept plus corticosteroid , versus cyclophosphamide plus corticosteroid induction phase follow azathioprine maintenance phase , maintain remission renal function patient lupus nephritis . Patients randomize receive CellCept 1g bid po plus corticosteroid 24 week , follow CellCept 0.75g bid po plus corticosteroid follow 24 week , cyclophosphamide 0.5-1.0g/m2 monthly plus corticosteroid 24 week , follow azathioprine 2mg/kg/day po plus corticosteroid follow 24 week . Response rate assess end induction phase , end study . The anticipated time study treatment 3-12 month , target sample size 100-500 individual .</brief_summary>
	<brief_title>A Study CellCept ( Mycophenolate Mofetil ) Patients With Lupus Nephritis .</brief_title>
	<detailed_description />
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Lupus Nephritis</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>adult patient , 1875 year age ; systemic lupus erythematosus ; histological diagnosis lupus nephritis . need immunosuppressive treatment ( addition corticosteroid ) ; continuous dialysis start &gt; 2 week randomization , anticipate duration &gt; 8 week ; previous plan kidney transplant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>